Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2524)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5694)
  2. Department of Medicine (5684)
  3. GSK Faculty (1658)
  4. Human Oncology and Pathogenesis Program (1157)
  5. Department of Pathology and Laboratory Medicine (1129)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (785)
  4. Dean Bajorin (664)
  5. Michael Morris (587)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (202)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (689)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5694)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 0 study to assess [111In]-DOTA-h11B6 to target -human kallikrein-2 (hk2) in men with metastatic castration-resistant prostate cancer
    Meeting Abstract

    Morris, M. J.; O'Donoghue, J. A.; Chetty, D.; Russell, M.; Zulch, E.; Avadhani, A. N.; Divgi, C. R.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Final analysis of the CheckMate 025 trial comparing nivolumab (NIVO) versus everolimus (EVE) with >5 years of follow-up in patients with advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Motzer, R. J.; Tykodi, S. S.; Escudier, B.; Oudard, S.; Hammers, H. J.; McDermott, D. F.; George, S.; Castellano, D.; Choueiri, T. K.; Alva, A. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The effect of abiraterone acetate treatment on CREB and the development of abiraterone acetate resistance in prostate cancer cells
    Meeting Abstract

    Pan, W.; Zhang, Z.; Kimball, H.; Qiu, F.; Lee, G. S. M.; Choueiri, T. K.; Kantoff, P. W.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Single-arm, phase II study to evaluate the safety and efficacy of sacituzumab govitecan in patients with metastatic castration-resistant prostate cancer who have progressed on second generation AR-directed therapy
    Meeting Abstract

    Lang, J. M.; Kyriakopoulos, C.; Slovin, S. F.; Eickhoff, J. C.; Dehm, S.; Tagawa, S. T.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Relationship between hyperphosphatemia with infigratinib (BGJ398) and efficacy in FGFR3-altered advanced/metastatic urothelial carcinoma (aUC)
    Meeting Abstract

    Lyou, Y.; Grivas, P.; Rosenberg, J. E.; Hoffman-Censits, J. H.; Quinn, D. I.; Petrylak, D. P.; Galsky, M. D.; Vaishampayan, U. N.; De Giorgi, U.; Gupta, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Genomic biomarkers of response to lenvatinib/pembrolizumab (Len/Pembro) in patients with advanced renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; DiNatale, R. G.; Chowell, D.; Krishna, C.; Makarov, V.; Shapnik, N.; Murray, S. J.; Carlo, M. I.; Voss, M. H.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer: A substudy of the VISION trial
    Meeting Abstract

    Kurth, J.; Herrmann, K.; Eiber, M.; Rahbar, K.; Heuschkel, M.; Lassmann, M.; Jentzen, W.; Chicco, D.; Messmann, R.; Sartor, A. O.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Evaluation of brain metastasis in JAVELIN Renal 101: Efficacy of avelumab + axitinib (A+Ax) versus sunitinib (S)
    Meeting Abstract

    Jonasch, E.; Hasanov, E.; Motzer, R. J.; Hariharan, S.; Choueiri, T. K.; Huang, B.; Haanen, J. B. A. G.; Albiges, L.; Venugopal, B.; Schmidinger, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Comparative circulating tumor DNA (ctD-NA) genomic profiling in 110 patients with advanced renal cell carcinoma
    Meeting Abstract

    Kotecha, R.; Gedvilaite, E.; Murray, S. J.; Foster, A.; Motzer, R. J.; Tsui, D.; Voss, M. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Rucaparib for recurrent, locally advanced, or metastatic urothelial carcinoma (mUC): Results from ATLAS, a phase II open-label trial
    Meeting Abstract

    Grivas, P.; Loriot, Y.; Feyerabend, S.; Morales-Barrera, R.; Teo, M. Y.; Vogelzang, N. J.; Grande, E.; Zakharia, Y.; Adra, N.; Alva, A. S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save